Amarin Corp Plc (AMRN)

[jaspirr]

Hayward:

I expect Amarin to settle before, or during, trial. Remember that Amarin has everything to lose, and the generic companies have nothing to lose. If the generics lose here, they'll just go chase down some other name-brand drug to compete against. They have 1000 products, Amarin has 1. I think Amarin has made some good, but not great, settlement offers and the generic companies are holding out because they know how important it is to Amarin.

To clarify your other question, I didn't say the generics have a 1% chance of winning. I said that today's ruling from the Judge increased their chance of winning by maybe 1% in the grand scheme of things. Overall I would give the generics a 15% chance of winning but please note I'm not a patent lawyer.